Skip to main content
Cipher Pharmaceuticals Inc. logo

Cipher Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · CPHRF ISIN · CA17253X1050 LEI · 213800T44AN9XSAOY605 TSX Manufacturing
Filings indexed 165 across all filing types
Latest filing 2023-08-10 Regulatory Filings
Country CA Canada
Listing TSX CPHRF

About Cipher Pharmaceuticals Inc.

https://www.cipherpharma.com/

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company focused on acquiring, marketing, and managing a diversified portfolio of commercial and pipeline products, primarily within the dermatology sector. The company seeks to fulfill unmet medical needs by acquiring best-in-class products and managing the necessary clinical development and regulatory processes. Its portfolio includes key commercial products such as Epuris (isotretinoin), an oral retinoid indicated for the treatment of acne. Cipher's strategy involves continually evaluating businesses with commercial products for merger or acquisition opportunities to expand its offerings.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-08-10 English
Interim MD&A - English.pdf
Regulatory Filings
2023-08-10 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-08-10 English
News release - English.pdf
Regulatory Filings
2023-08-10 English
Report of voting results.pdf
Regulatory Filings
2023-06-22 English
News release - English.pdf
Regulatory Filings
2023-06-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.